NDC 49288-0062

Canadian Bluegrass

Canadian Bluegrass

Canadian Bluegrass is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Poa Compressa Pollen.

Product ID49288-0062_0247493a-8221-44f5-afa6-071bde3bfac2
NDC49288-0062
Product TypeHuman Prescription Drug
Proprietary NameCanadian Bluegrass
Generic NameCanadian Bluegrass
Dosage FormInjection, Solution
Route of AdministrationINTRADERMAL; SUBCUTANEOUS
Marketing Start Date1974-03-23
Marketing CategoryBLA / BLA
Application NumberBLA102223
Labeler NameAntigen Laboratories, Inc.
Substance NamePOA COMPRESSA POLLEN
Active Ingredient Strength0 g/mL
Pharm ClassesNon-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 49288-0062-3

10 mL in 1 VIAL, MULTI-DOSE (49288-0062-3)
Marketing Start Date1974-03-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49288-0062-5 [49288006205]

Canadian Bluegrass INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0062-1 [49288006201]

Canadian Bluegrass INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0062-2 [49288006202]

Canadian Bluegrass INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0062-4 [49288006204]

Canadian Bluegrass INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0062-3 [49288006203]

Canadian Bluegrass INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
POA COMPRESSA POLLEN.05 g/mL

OpenFDA Data

SPL SET ID:c7d383a6-94b8-4101-8a4c-fa7747a21468
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 889573
  • 852676
  • 852517
  • 852346
  • 852228
  • 852220
  • 1232641
  • 1006509
  • 1115952
  • 889671
  • 898407
  • 1098458
  • 852117
  • 852018
  • 852332
  • 852662
  • 852139
  • 852135
  • 1014777
  • 1014738
  • 1014734
  • 852700
  • 898132
  • Pharmacological Class

    • Non-Standardized Pollen Allergenic Extract [EPC]
    • Increased Histamine Release [PE]
    • Cell-mediated Immunity [PE]
    • Increased IgG Production [PE]
    • Pollen [CS]
    • Allergens [CS]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.